Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine

Dev Biol Stand. 1993:78:93-9; discussion 99-100.

Abstract

Sequence analysis of poliovirus vaccine RNA has resulted in the identification of a new point mutation at position 2493 in Sabin 3. cDNA-derived Sabin 3 virus whose genome includes the new mutation has phenotypic properties expected for a vaccine strain. Virus engineered to contain a single base substitution at 2493 has lost the small plaque phenotype, and low neurovirulence characteristics normally associated with Sabin poliovirus strains. The significance of these observations and a potential relationship to the frequency of vaccine-associated poliomyelitis are described.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Base Composition
  • DNA / genetics
  • Humans
  • Macaca mulatta
  • Mice
  • Mice, Transgenic
  • Mutation*
  • Poliomyelitis / epidemiology
  • Poliomyelitis / etiology
  • Poliomyelitis / pathology
  • Poliovirus / genetics*
  • Poliovirus / pathogenicity
  • Poliovirus Vaccine, Oral* / adverse effects
  • Poliovirus Vaccine, Oral* / toxicity
  • RNA, Viral / genetics*
  • United States / epidemiology
  • Vero Cells
  • Virulence / genetics

Substances

  • Poliovirus Vaccine, Oral
  • RNA, Viral
  • DNA